Home › APOLLOHOSP › Filing
🔔 Get instant alerts when APOLLOHOSP files quarterly results on BSE Start free trial →

Analysts/Institutional Investor Meet/Con. Call Updates

Filed: 04 Nov 2026, 18:47 IST Exchange: NSE Category: Financial Results — Investor Presentation
Press Release - Q2FY27 - Consolidated revenue grew 23% to ₹76,149 mio; EBITDA up 29% to ₹11,910 mio; PAT rose 32% to ₹6,301 mio - Healthcare Services revenue up 23%, volume +14%, with Oncology +28%, Gastro +27%, Cardiac +20%, Ortho +20%, Urology +26% - AHLL revenue and EBITDA grew 20% and 79% YoY respectively, driven by 24% diagnostics growth - Apollo HealthCo digital segment turned EBITDA positive; platform GMV grew 27% YoY - Expansion plan includes 4,198 new beds with ₹11,150 cr capex; 5 new hospitals commissioned - Composite scheme approved for demerger and listing of Apollo HealthCo by Q4FY27 - Digital cash profit improved significantly, reducing losses by ₹400 mio YoY
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 APOLLOHOSP — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add APOLLOHOSP to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Apollo Hospitals Enterprise Limited

Important. The summary above is generated automatically from Apollo Hospitals Enterprise Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.